Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of…
The sleep medicine guideline actually recommends against melatonin for ongoing insomnia — if that's what I have, what would you use instead, and is CBT for insomnia available to me?
Top of the evidence hierarchy, independently funded. how we score evidence
Caveat on this rating: All 14 recommendations in this guideline are WEAK, including the ones in favour of prescription hypnotics, and the task force explicitly notes that evidence quality is routinely downgraded because most hypnotic trials are industry-funded. So the guidance against melatonin sits in a field of uniformly thin evidence rather than reflecting a uniquely poor showing. Several task-force members disclosed industry consulting relationships and recused themselves from the corresponding drug recommendations.
In the United States melatonin is sold over the counter as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA).
After a GRADE-based systematic review of randomized trials, the American Academy of Sleep Medicine's guideline states: "We suggest that clinicians not use melatonin as a treatment for sleep onset or sleep maintenance insomnia (versus no treatment) in adults." That is a recommendation against, in the same list that recommends against valerian, tryptophan, trazodone, and diphenhydramine. The recommendation is graded WEAK, which under GRADE reflects low certainty of the underlying evidence rather than a strong claim that melatonin is useless — but it is a recommendation not to use it.
Worth asking
The sleep medicine guideline actually recommends against melatonin for ongoing insomnia — if that's what I have, what would you use instead, and is CBT for insomnia available to me?
Source
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. — Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. (2017)
Reputable peer-reviewed journal
Read the source: https://doi.org/10.5664/jcsm.6470
DOI: 10.5664/jcsm.6470
How this was scored
- Study design
- National clinical guideline
- Funding
- Independently funded
- Published in
- Reputable peer-reviewed journal
- Sample size
- not recorded
- Preregistered
- No
- Conflicts disclosed
- Yes
- Independent of proponent
- Yes
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026.
Where we put this study in context
Questions
How strong is the evidence behind this?
Resolv rates this source "gold standard". Top of the evidence hierarchy, independently funded. It scores 86 out of 100 on our published rubric. One caveat travels with that badge: All 14 recommendations in this guideline are WEAK, including the ones in favour of prescription hypnotics, and the task force explicitly notes that evidence quality is routinely downgraded because most hypnotic trials are industry-funded. So the guidance against melatonin sits in a field of uniformly thin evidence rather than reflecting a uniquely poor showing. Several task-force members disclosed industry consulting relationships and recused themselves from the corresponding drug recommendations. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. — Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. (2017). Published in: Reputable peer-reviewed journal. DOI: 10.5664/jcsm.6470. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: National clinical guideline. Funding: Independently funded. The researchers were independent of whoever benefits from the result. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is melatonin, circadin, slenyto, n-acetyl-5-methoxytryptamine, melatonin gummies FDA approved for this use?
No. Its current status is: Not FDA-evaluated for this use. In the United States melatonin is sold over the counter as a dietary supplement under the Dietary Supplement Health and Education Act of 1994 (DSHEA).
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.